Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2026-02-22 @ 6:43 PM
Study NCT ID:
NCT02586051
Status:
COMPLETED
Last Update Posted:
2020-01-29
First Post:
2015-10-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Obinutuzumab to Evaluate Safety and Tolerability in Hypersensitized Adult Participants With End Stage Renal Disease Awaiting Transplantation
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11-19
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-11-26
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-23
First Submit QC Date:
None
Study First Post Date:
2015-10-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-01-27
Last Update Post Date:
2020-01-29
Last Update Post Date Type:
ACTUAL